The history and future of hemostasis research (To the anniversary of Kirov Research Institute of Hematology and Blood Transfusion FMBA of Russia): 616-01:573.7
Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)

Keywords

hemostasis
coagulation
history
development prospects

Abstract

Summary. The article highlights some of the stages in hemostasiology development as a scientific direction. A certain part of the work is devoted to the evolution of this branch of medicine, to the achievements of eminent domestic researchers, highlighted the immediate and further prospects of scientific research. The lessons learned allows to hope for advancing knowledge on the blood coagulation issues and the formation of the specialty “hemostasiology” in the Russian Federation to the professional and patient-oriented care of different patient groups accompanied by blood coagulation disorders.

References:

  1. Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science. 1964;145(3638):1310–2. DOI: 10.1126/sci- ence.145.3638.1310. 

  2. Macfarlane R. G. An enzyme cascade in the blood clotting mechanism and its function as biochemical amplifier. Nature. 1964;202:498–9. DOI: 10.1038/202498a0. 

  3. Hoffman M., Monroe D.M. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–65. 

  4. Brinkmann V., Reichard U., Goosmann C. et al. Neutrophil extra- cellular traps kill bacteria. Science. 2004;303(5663):1532–35. DOI: 1126/science.1092385. 

  5. Oehmcke S., Mörgelin M., Herwald H. Activation of the human contact system on neutrophil extracellular traps. J Innate Immun. 2009;1(3):225–30. DOI: 10.1159/000203700. 

  6. Fuchs T.A., Brill A., Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107(36):15880– DOI: 10.1073/pnas.1005743107. 

  7. Wolf P. The nature and significance of platelet products in human Br J Haematol. 1967;13(3):269–88. DOI: 10.1111/j.1365– 2141.1967.tb08741.x. 

  8. Sinauridze E.I., Kireev D.A., Popenko N.Y. et al. Platelet micropar- ticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(3):425– DOI: 10.1160/th07–03–0217. 

  9. 
Ignat’ev S.V., Lyanguzov A.V. The functional role of microvesi- cles in norm and pathology. Klinicheskaya fiziologiya krovoobrash- cheniya. 2019;16(4) 261–6. (In Russ.). DOI: 10.24022/1814–69102019– 16–4–261–266. 

  10. Zubairov D.M., Zubairova L.D. Microvesicles in the blood. Func- tions and their role in thrombus formation. GEOTAR-Media, 2009. 168 рр. (In Russ.). 

  11. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938–49. DOI: 10.1056/NEJMra0801082. 

  12. Pathophysiological peculiarities of cancer-associated thrombosis specifying opportunities of therapy with direct oral anticoagu- lants. Tromboz, gemostaz i reologiya. 2019;(2):22–30. (In Russ.). DOI: 10.25555/THR.2019.2.0876.
  13. Zarà M., Guidetti G.F., Camera M. et al. Biology and role of extra- cellular vesicles (EVs) in the pathogenesis of thrombosis. Int J Mol Sci. 2019;20(11):2840. DOI: 10.3390/ijms20112840.
  14. Gomzikova M.O., Gayfullina R.F., Mustafin I.G. et al. Membrane microvesicles: biological properties and involvement in pathogen- esis of diseases. Kletochnaya transplantologiya i tkanevaya inzhener- iya. 2013;8(1):6–11. (In Russ.).
  1. Momot A. P., Tsarigorodtseva N. O., Fedorov D. V. et al. Plate- let microvesicles and their role in providing hemostatic capac- ity (literature review). Sibirskij nauchnyj medicinskij zhurnal. 2020;40(2):4–14. (In Russ.). DOI: 10.15372/SSMJ20200201.
  1. Arraud N., Linares R., Tan S. et al. Extracellular vesicles from blood plasma: determination of their morphology, size, pheno- type and concentration. J Thromb Haemost. 2014;12(5):614–27. DOI: 1111/jth.12554.
  2. Müller I., Klocke A., Alex M. et al. Intravascular tissue factor initi- ates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17(3):476–8. DOI: 10.1096/fj.02–0574fje.
  3. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011;108(10):1284–97. DOI: 10.1161/CIRCRE- SAHA.110.233056.
  4. Anderson H.C., Mulhall D., Garimella R. Role of extracellular mem- brane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest. 2010;90(11):1549–57. DOI: 10.1038/labinvest.2010.152.
  5. Pap E., Pállinger E., Falus A. The role of membrane vesicles in tumorigenesis. Crit Rev Oncol Hematol. 2011;79(3):213–23. DOI: 10.1016/j.critrevonc.2010.07.015.
  6. Panteleev M.A., Abaeva A.A., Nechipurenko D. Yu. et al. Physiol- ogy and pathology of extracellular vesicules. Onkogematologiya. 2017;12(1):62–70. (In Russ.). DOI: 10.17650/1818–8346–2017–12– 1–62–70.
  7. Ermolina E.V. If it was not Barkagan... Touches for the portrait of the luminary. Altajskaya pravda. October 28, 2011. (In Russ.). Avail- able at: https://www.ap22.ru/paper/paper_5267.html.